CYTOTIL15
Live / Registered — Registered (as of 21 Oct 2025)
What this means for you
Registered since 21 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90710889
- Registration number
- 7995058
- Mark type
- Stylized text
- Filed
- 14 May 2021
- Published for opposition
- 01 Mar 2022
- Registered
- 21 Oct 2025
- Attorney of record
- Olivia Maria Baratta
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of cells for medical or clinical use for others; Custom manufacture of pharmaceutical preparations for others in the fields of cell therapy, gene therapy, regenerative medicine and biopharmaceuticals; Custom manufacture of biological preparations for others for the treatment of cancer
- Class 042 — Scientific and technological services: Medical and scientific research and development services in the fields of cell therapy, gene therapy, oncology, and immunotherapy
Owner
- Obsidian Therapeutics, Inc., Cambridge, MA, US
- Obsidian Therapeutics, Inc., Cambridge, MA, US
- Obsidian Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 21 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 01 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Apr 2025 — USE AMENDMENT FILED
- 05 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Apr 2025 — TEAS STATEMENT OF USE RECEIVED
- 24 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2024 — SOU EXTENSION 5 GRANTED
- 24 Oct 2024 — SOU EXTENSION 5 FILED
- 24 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 25 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Apr 2024 — SOU EXTENSION 4 GRANTED
- 24 Apr 2024 — SOU EXTENSION 4 FILED